← All candidates
13 insider buys in the last year — $1.71M in all.
17 filings on record.
NXTCNextCure, Inc.
NasdaqGS · Healthcare · $32.04M
$7.00
-5.97% · Sep 17
13 insider buys in the last year — $1.71M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 13 buys● 1 sell◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what NXTC ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$32.04M
Float
2.9M
64% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
ADAR1 Capital Management, LLC
Bought $490.0K on Jul 30 — 100,000 sh @ $4.90, held indirect, 16% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
9 more transactions on Pro →Context
Wall St
$20.00 avg target
+185.7% vs today · 3 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$1.87 act+$0.16
Q4 '25−$0.81 act+$1.48
Q3 '25−$3.22 act+$0.76
Q2 '25−$11.29 act−$6.67
Coverage
Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?Zacks · 11-11Companies Like NextCure (NASDAQ:NXTC) Could Be Quite RiskySimply Wall St. · 10-18Sector Update: Healthcare Stocks Fall Late AfternoonMT Newswires · 07-14Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillBioPharma Dive · 07-14
The file stays open
17 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice